New cinnamic acid-pregenolone hybrids as potential antiproliferative agents: Design, synthesis and biological evaluation. 2019

Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
School of Biological Science and Technology, University of Jinan, Jinan 250022, China.

A series of new cinnamic acid-pregenolone hybrids (5a-5o) was designed, synthesized and evaluated for their in vitro antiproliferative activity. Some of them showed potential antiproliferative activity and selectivity towards a panel of cancer cell lines, including A549, H157, HepG2, MCF-7, and HL-60. Among these analogs, compound 5f showed the most promising activity with IC50 values ranging from 3.2 to 6.8 μM, and it was taken as a model compound in the following antiproliferative mechanism study. In Hoechst 33258 staining assay, 5f-treated A549 cells displayed significant apoptosis characteristics. Flow cytometry analysis revealed that 5f showed the antiproliferative activity against A549 via G1 cell cycle arrest and inducing apoptosis. Western blotting analysis demonstrated that 5f enhanced apoptosis of A549 cells by down-regulating Bcl-2 and up-regulating Bax protein expression. The present study highlighted this series of cinnamic acid-pregenolone hybrids as a new antiproliferative lead prototype.

UI MeSH Term Description Entries
D011284 Pregnenolone A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS. 5-Pregnen-3-beta-ol-20-one,5 Pregnen 3 beta ol 20 one
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002934 Cinnamates Derivatives of cinnamic acid (the structural formula: phenyl-HC Cinnamate
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
October 2022, European journal of medicinal chemistry,
Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
November 2014, Molecules (Basel, Switzerland),
Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
March 2011, Journal of medicinal chemistry,
Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
May 2021, ChemMedChem,
Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
June 2020, Bioorganic chemistry,
Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
January 2016, Anti-cancer agents in medicinal chemistry,
Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
October 2017, European journal of medicinal chemistry,
Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
June 2023, European journal of medicinal chemistry,
Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
December 2022, Chemico-biological interactions,
Yong-Xi Ge, and Yan-Hong Wang, and Juan Zhang, and Zhi-Pu Yu, and Xin Mu, and Jia-Li Song, and Yin-Yin Wang, and Feifei Yang, and Ning Meng, and Cheng-Shi Jiang, and Hua Zhang
May 2018, European journal of medicinal chemistry,
Copied contents to your clipboard!